Editorial: Targeting Metabolism in Cancer Immunotherapy

about

Editorial: Targeting Metabolism in Cancer Immunotherapy

Item

http://www.wikidata.org/entity/Q58750674

description

scientific article published on 11 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Editorial: Targeting Metabolism in Cancer Immunotherapy

@en

Editorial: Targeting Metabolism in Cancer Immunotherapy

@nl

type

Item

label

Editorial: Targeting Metabolism in Cancer Immunotherapy

@en

Editorial: Targeting Metabolism in Cancer Immunotherapy

@nl

prefLabel

Editorial: Targeting Metabolism in Cancer Immunotherapy

@en

Editorial: Targeting Metabolism in Cancer Immunotherapy

@nl

P1476

Editorial: Targeting Metabolism in Cancer Immunotherapy

@en

P2093

Keiji Tanese

http://www.w3.org/2001/XMLSchema#string

Suhendan Ekmekcioglu

http://www.w3.org/2001/XMLSchema#string

P2860

Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells

Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives.

IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy.

Commentary: Induction of Dormancy in Hypoxic Human Papillomavirus-Positive Cancer Cells.

P304

2029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3389/FIMMU.2018.02029

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason Roszik

P577

2018-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30254633

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

6141691

http://www.w3.org/2001/XMLSchema#string